» Articles » PMID: 17118765

Donor-type Myelodysplastic Syndrome with T(2;3) and Monosomy 7 After Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-type Aplastic Anemia

Overview
Journal Int J Hematol
Specialty Hematology
Date 2006 Nov 23
PMID 17118765
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Secondary clonal hemaloiogical disease in donor cells has rarely been reported as a complication of allogeneic stem cell transplantation in hematological disease. We report a case of myelodysplastic syndrome that showed cytogenetic abnormalities of t(2;3) and monosomy 7, which developed 2 years after peripheral blood stem cell transplantation for aplastic anemia and 1 year after liver transplantation for drug-induced hepatic failure. This secondary malignancy of donor origin is most frequently seen in patients with leukemia. We suspect that the chromosomal abnormalities are related to hepatitis-associated aplastic anemia, administration of granulocyte colony-stimulating factor and erythropoietin for posttransplantion pancytopenia, and repeated infections after liver transplantation.

Citing Articles

Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature.

Deshmukh K, Kelemen K Life (Basel). 2022; 12(4).

PMID: 35455050 PMC: 9028156. DOI: 10.3390/life12040559.


Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.

Williams L, Doucette K, Karp J, Lai C Bone Marrow Transplant. 2021; 56(7):1535-1549.

PMID: 33686252 DOI: 10.1038/s41409-021-01214-z.


Leukemic Transformation of Severe Aplastic Anemia Following Matched Allogenic Stem Cell Transplantation, Transplanted Again in CR 1.

Manivannan P, Purohit A, Somasundaram V, Ahuja A, Aggarwal M, Kumar R Indian J Hematol Blood Transfus. 2016; 32(Suppl 1):223-7.

PMID: 27408397 PMC: 4925474. DOI: 10.1007/s12288-014-0484-z.


Development of donor cell leukemia following peripheral blood stem cell transplantation for severe aplastic anemia: A case report.

Ma H, Liu T Oncol Lett. 2016; 11(6):3858-3862.

PMID: 27313707 PMC: 4888078. DOI: 10.3892/ol.2016.4452.


Monosomy 7 in donor cell-derived leukemia after bone marrow transplantation for severe aplastic anemia: Report of a new case and review of the literature.

Otero L, Correa de Souza D, de Cassia Tavares R, Gomes B, Padilha T, Bouzas L Genet Mol Biol. 2012; 35(4):734-6.

PMID: 23271931 PMC: 3526078. DOI: 10.1590/S1415-47572012005000056.


References
1.
Boyd C, Ramberg R, Thomas E . The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. Leuk Res. 1982; 6(6):833-7. DOI: 10.1016/0145-2126(82)90067-4. View

2.
Flactif M, Lai J, Preudhomme C, Fenaux P . Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes. Leukemia. 1994; 8(6):1012-8. View

3.
Bhatia S, Ramsay N, Steinbuch M, Dusenbery K, Shapiro R, Weisdorf D . Malignant neoplasms following bone marrow transplantation. Blood. 1996; 87(9):3633-9. View

4.
Abeliovich D, Yehuda O, Nagler A, Lerer I, Ben-Neriah S, Amar A . Predominant 45,X,--Y karyotype in donor cells after allogeneic BMT: cytogenetic and molecular analysis. Cancer Genet Cytogenet. 1996; 86(1):1-7. DOI: 10.1016/0165-4608(95)00170-0. View

5.
Ohara A, Kojima S, Okamura J, Inada H, Kigasawa H, Hibi S . Evolution of myelodysplastic syndrome and acute myelogenous leukaemia in children with hepatitis-associated aplastic anaemia. Br J Haematol. 2002; 116(1):151-4. DOI: 10.1046/j.1365-2141.2002.03229.x. View